Elan Corporation

Pharmaceutical company

About Us

Products

Elan Drug Technologies

Research & Development

News

Investor Relations

Careers

Governance

• NanoCrystal® Technology
• Oral Controlled Release Technology
• Case Studies
• Clients and Products
• Contract Manufacturing, Scale-up & Development
• Sterile Vial Fill & Finish
• Elan Drug Technologies News
• Calendar of Events
• Published Materials
• Contact Us

Announcements

29 October 2007	Elan Announces the Johnson & Johnson Pharmaceutical Research & Development Submission of a New Drug Application to the FDA for Paliperidone Palmitate Using Elan's Proprietary NanoCrystal® Technology
6 March 2007	Amarin Expands Neurology Pipeline With Epilepsy Product Candidate
5 Sept 2006	ADDITIONAL NANOCRYSTAL® TECHNOLOGY PATENT ISSUED COVERING PAR’S MEGACE ®ES
6 Jul 2006	Elan Signs License Agreement with Abbott for Elan's Proprietary NanoCrystal(R) Technology; To Develop a Single Fixed-Dose Combination of TriCor(R) and Crestor(R) for High Cholesterol Patients
10 Jan 2006	Elan and EntreMed Execute License Agreement for Proprietary NanoCrystal® Technology
27 July 2005	MAP Pharmaceuticals Announce  Expanded Development Agreement With Elan Drug Technologies Proprietary Elan NanoCrystal® Technology to be Applied to MAP’s Novel Asthma Therapeutics
06 July 2005	Par Pharmaceutical Announces FDA Approval of Megace(R) ES for Anorexia, Cachexia, or an Unexplained, Significant Weight Loss in Patients With a Diagnosis of AIDS
07 Feb 2005	Japanese Patent Office Issues Patent Certificate to Elan for Its NanoCrystal-TM- Technology
12 Jan 2005	Elan's Proprietary NanoCrystal® Technology is Used by Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&J PRD) in Phase III Clinical Trial of Paliperidone Palmitate
07 Jan 2005	Elan and Roche Expand Nanocrystal Technology License
14 Jun 2004	Announcement on the establishment of new Sterile Biopharmaceuticals Plant at its Athlone, Ireland facility
10 Jun 2004	Elan Announces Manufacturing Agreement with Lilly
21 Apr 2004	Elan NanoSystems licenses NanoCrystal™ technology to Roche
20 Jan 2004	Elan NanoSystems licenses NanoCrystal™ technology to Aventis
13 Oct 2003	Elan's NanoSystems licenses NanoCrystal® to Janssen
30 Sep 2003	Elan's NanoSystems and Bristol-Myers Squibb sign license
20 May 2003	Merck and Elan Announce NanoCrystal® Technology is Formulation for Merck’s Emend® (aprepitant)
30 Aug 2000	Elan announces first U.S. approval for its NanoCrystal™ technology

Copyright © 2001- 2004 Elan Corporation, plc, Dublin, Ireland. All rights reserved. | Privacy Policy | Terms of use